It is worth noting that of the 14 genes identified as significantly differentially expressed between GNAQ/GNA11 and CYSLTR2 mutant UM patient samples in TCGA, PRAME (preferentially expressed in melanoma) has previously been identified as independent marker of metastasis in UM71 (Supplementary Fig. 4b). This evidence concerns the gene CYSLTR2 and melanoma.